1. A distinct biomarker of continuous transcutaneous vagus nerve stimulation treatment in major depressive disorder
- Author
-
Bing Zhu, Jiliang Fang, Peijing Rong, Zengjian Wang, Guo-Lei Zhang, Jun Liu, Courtney Lang, Yiheng Tu, Jin Cao, Kristen Jorgenson, Jian Kong, Joel Park, and Yan-Ping Zhao
- Subjects
Adult ,Male ,0301 basic medicine ,Adolescent ,Vagus Nerve Stimulation ,medicine.medical_treatment ,Hypothalamus ,Biophysics ,Major depressive disorder ,Article ,lcsh:RC321-571 ,Young Adult ,Functional connectivity ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,Longitudinal Studies ,Rostral anterior cingulate cortex ,Transcutaneous vagus nerve stimulation ,lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry ,Anterior cingulate cortex ,Depression (differential diagnoses) ,Aged ,Depressive Disorder, Major ,business.industry ,General Neuroscience ,Brain ,Medial Hypothalamus ,Vagus Nerve ,Biomarker ,Middle Aged ,medicine.disease ,Magnetic Resonance Imaging ,Treatment Outcome ,030104 developmental biology ,medicine.anatomical_structure ,Anesthesia ,Transcutaneous Electric Nerve Stimulation ,Biomarker (medicine) ,Female ,Neurology (clinical) ,business ,Biomarkers ,030217 neurology & neurosurgery ,Vagus nerve stimulation - Abstract
Background Major depression is the fourth leading cause of disability worldwide and poses a socioeconomic burden worldwide. Transcutaneous vagus nerve stimulation (tVNS) is a promising noninvasive clinical device that may reduce the severity of major depression. However, the neural mechanism underlying continuous tVNS has not yet been elucidated. Objective We aimed to explore the effect of hypothalamic subregion functional connectivity (FC) changes during continuous tVNS treatment on major depressive disorder (MDD) patients and to identify the potential biomarkers for treatment outcomes. Methods Forty-one mild to moderate MDD patients were recruited and received either real or sham tVNS treatment for 4 weeks. We used a seed-to-whole brain approach to estimate the FC changes of hypothalamic subregions and their surrounding control areas during continuous tVNS treatment and explored their association with clinical outcome changes after 4 weeks of treatment. Results Of the thirty-six patients that completed the study, those in the tVNS group had significantly lower scores on the 24-item Hamilton Depression (HAM-D) Rating Scale compared to the sham tVNS group after 4 weeks of treatment. The FC between the bilateral medial hypothalamus (MH) and rostral anterior cingulate cortex (rACC) was significantly decreased during tVNS but not during sham tVNS. The strength of this FC was significantly correlated with HAM-D improvements after 4 weeks of tVNS. Conclusion The FC between the bilateral MH and rACC may serve as a potential biomarker for the tVNS state and predict treatment responses. Our results provide insights into the neural modulation mechanisms of continuous tVNS and reveal a potential therapeutic target for MDD patients.
- Published
- 2018
- Full Text
- View/download PDF